PCVX - Vaxcyte, Inc. Common Stock

Day 1m 10m 60m PreMarket Market AfterHours Gap
42.92 1.05 (2.45%) --- --- --- 0.17 (0.4%) 1.09 (2.54%) -0.77 (-1.88%) 2.23 (5.46%)

Vaxcyte Inc is a clinical-stage vaccine innovation company engineering high-fidelity vaccines to protect humankind from the consequences of bacterial diseases. It is developing broad-spectrum conjugate and novel protein vaccines to prevent or treat bacterial infectious diseases. Its product comprises of Pneumococcal conjugate vaccine. The firm's product candidate consists of VAX-31, VAX-24, VAX-A1, VAX-PG, VAX-GI, and Others.

Category: BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)
Market Period: Closed

Earnings & Ratios

Basic EPS:
-1.22
Diluted EPS:
-1.22
Basic P/E:
-36.041
Diluted P/E:
-36.041
RSI(14) 1m:
61.33
VWAP:
43.97
RVol:
0.7584

Events

Period Kind Movement Occurred At

Related News